Jump to Navigation
Trends and Sentiments
Comments and Analysis
Bitcoin-mining company Butterfly Labs shut down by FTC
The Expert View: AstraZeneca, Mothercare and Home Retail
Samsung to launch new phone in China before Apple
Citizens Financial's IPO priced at $21.50
IPO Preview: Medley Management
China bourses buck Asia downward trend
Delhi property market staring at a slump under new circle...
UK: Islamic Bank of Britain appoints Keith Leach to newly...
SEC probes ETF for inflated returns
India successfully puts Mars Orbiter into orbit of red...
Technology Leads Week With 5 IPO filings; 5 More Added To Calendar
8 U.S. IPOs Planned For The Week
IPO Preview: Cempra Holdings
2 Life Sciences IPOs Debut Below Target
Caesars Stands Out In A Busy IPO Week With Strong Returns
Trius Therapeutics: The Calm Before The Storm
2012 Biotech IPOs: Age Of The Dreamers?
2 Promising Biopharma Companies To Examine
Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured
Companies That Can Mend The Biotech Market: Stephen Brozak
Cempra's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Cempra Management Discusses Toyama Exclusive Agreement Conference (Transcript)
Cempra's CEO Presents at BARDA Contract Award Conference (Transcript)
Can Cempra Beat The Superbugs?
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Cempra's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Cempra's CEO Discusses Q3 2013 Results - Earnings Call Transcript
This Antibiotic Play May Be The Trius Of 2014
Cempra Holdings Hosts Solithromycin and Taksta Clinical Update Conference Call (Transcript)
Do Away With The Pill-A-Day Biotech Model: Steve Brozak
Cempra: Safety Results Solidifying Market Position
Cempra's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Promising Biotechs Target New Ways To Kill Bad Bugs: Venture Capitalist Dennis Purcell
Cempra's CEO Discusses Q1 2014 Results - Earnings Call Transcript
United Nations star power: A look at some...
The Hollywood Taxidermist Raising the (Small,...
EUR/GBP: 1.2764 USD/EUR: 1.2857 JPY/USD: 108.535
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions